Thomas K Equels
CEO, President at AIM ImmunoTech Inc. (AIM)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$2K
Total bought / sold$13K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 18SEC | AIMAIM ImmunoTech Inc. | Buy | 24,000126,822 held (+23%) | $0.21 | $5K | -14.3% |
| Sep 17SEC | AIMAIM ImmunoTech Inc. | Buy | 11,000102,822 held (+12%) | $0.21 | $2K | -14.3% |
| Sep 16SEC | AIMAIM ImmunoTech Inc. | Buy | 22,00091,822 held (+32%) | $0.22 | $5K | -18.2% |
| Sep 15SEC | AIMAIM ImmunoTech Inc. | Buy | 5,90069,822 held (+9%) | $0.22 | $1K | -18.2% |
- Buy
CEO, President Thomas K Equels bought $5K of AIM at $0.21 — raises the stake by 23%.
- Buy
CEO, President Thomas K Equels bought $5K of AIM at $0.22 — largest purchase by this insider in our records; raises the stake by 32%.
- Buy
CEO, President Thomas K Equels bought $1K of AIM at $0.22 — first open-market purchase in our records.